JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

We present protocols for the collection, preparation, and imaging of mature Drosophila oocytes. These methods allow the visualization of chromosome behavior and spindle assembly and function during meiosis.

Streszczenie

Chromosome segregation in human oocytes is error prone, resulting in aneuploidy, which is the leading genetic cause of miscarriage and birth defects. The study of chromosome behavior in oocytes from model organisms holds much promise to uncover the molecular basis of the susceptibility of human oocytes to aneuploidy. Drosophila melanogaster is amenable to genetic manipulation, with over 100 years of research, community, and technique development. Visualizing chromosome behavior and spindle assembly in Drosophila oocytes has particular challenges, however, due primarily to the presence of membranes surrounding the oocyte that are impenetrable to antibodies. We describe here protocols for the collection, preparation, and imaging of meiosis I spindle assembly and chromosome behavior in Drosophila oocytes, which allow the molecular dissection of chromosome segregation in this important model organism.

Wprowadzenie

The study of meiosis is sometimes described as the "genetics of genetics". This is because the fundamental properties of chromosome inheritance and independent assortment are carried out through the segregation of chromosomes during gamete production. An important demonstration of the chromosome theory of inheritance came in 1916 from the work of Calvin Bridges in Drosophila melanogaster1. This and other classical genetics studies in Drosophila contributed greatly to our understanding of genetics. Cytological examination of meiotic chromosomes in Drosophila oocytes, however, has been challenging. This is primarily because immunofluorescence of late-stage Drosophila oocytes, when the spindle assembles and chromosomes are oriented for segregation, is hampered by the presence of membranes that render the oocyte impenetrable to antibodies.

Despite this challenge, Drosophila oocytes remain an attractive model for the study of chromosome behavior and spindle assembly. This is because of the powerful genetic tools available in Drosophila, but also because the oocytes arrest at metaphase I, when the chromosomes are oriented and the spindle is fully formed. This facilitates the collection and examination of large numbers of oocytes at this important stage of cell division. In addition, a simple model organism that is amenable to genetic manipulation for the study of oocyte chromosome segregation can provide an important contribution to our understanding of human reproductive health. Errors in chromosome number are the leading genetic cause of miscarriage and birth defects in humans2. A majority of these errors can be traced to the oocyte and are correlated with increasing maternal age. The average age of mothers in the U.S. has been increasing, making this a major public health concern.

We describe here methods for the cytological examination of Drosophila oocytes, including a demonstration of how to remove the oocyte membranes. These methods are modifications of protocols first described by Theurkauf and Hawley3, Zou et al.4, and Dernburg et al.5. We also include methods for the enrichment of different stages of oocytes, based on a protocol first described by Gilliland et al.6. Finally, we add instructions for the drug treatment of Drosophila oocytes. Together, these methods allow the cytological investigation of oocyte chromosome segregation and spindle assembly in Drosophila.

Protokół

Note: Procedures are performed at room temperature unless otherwise noted. Temperature-controlled incubators are used to maintain temperatures for fly rearing and crosses unless otherwise noted.

1. Preparations

  1. Prepare Flies.
    1. Prometaphase-enriched oocyte collections.
      1. Clear adult flies from healthy, young stock or cross cultures. Age bottles for two days at 25 °C.
        ​NOTE: Generally two healthy bottles will suffice, although more may be needed for some cross cultures.
      2. After two days, collect ~100 to 300 females (who are 0 to 2 days old at this point) from the bottles. The females do not need to be virgins. Add a dab of yeast paste to the side of a vial and place 30 females and 10 to 15 males each into the yeasted vials. Age vials for two days at 25 °C.
    2. Metaphase-enriched Oocyte Collections.
      1. Collect ~100 to 300 females from stock or cross cultures. Add a dab of yeast paste to the side of a vial and place 30 females each (with no males added) into the yeasted vials. Age vials for three to five days at 25 °C.
  2. Prepare Solutions.
    ​Note: Solutions may be stored indefinitely at room temperature, unless otherwise noted.
    1. Prepare Modified Robb's Buffer (5x): 500 mM HEPES, 500 mM sucrose, 275 mM sodium acetate, 200 mM potassium acetate, 50 mM glucose, 6 mM magnesium chloride, and 5 mM calcium chloride. Use 10 N 11:8 sodium hydroxide:potassium hydroxide to bring pH to 7.4. Sterilize by filtration; do not autoclave. Store at -20 °C. Thaw as needed to prepare ~200 ml of 1x Robb's per oocyte prep.
    2. Fixation Solutions.
      1. Option #1: Prepare formaldehyde/heptane fixation. Prepare Fixation Buffer: 1x phosphate-buffered saline (PBS) plus 150 mM sucrose. To use, make fresh with 687.5 µl Fixation Buffer and 312.5 µl 16% formaldehyde per oocyte prep.
        CAUTION: Wear gloves while using formaldehyde solutions in a fume hood. Dispose of waste according to institutional guidelines.
      2. Option #2: Prepare formaldehyde/cacodylate fixation. Prepare Fix Mix: 250 mM sucrose, 100 mM potassium acetate (pH 7.5), 25 mM sodium acetate (pH 7.0), and 25 mM EGTA (pH 8.0). To use, make fresh with 400 µl Fix Mix, 100 µl potassium cacodylate (1 M, pH 7.2), and 500 µl 16% formaldehyde per oocyte prep.
        ​CAUTION: Potassium cacodylate contains Arsenic.
    3. Prepare PBS/Triton X-100: 1x PBS plus 1% or 0.05% Triton X-100. Store at 4 °C.
    4. Prepare PBS-Tween 20-Bovine Serum Albumin (BSA) (PTB): 1x PBS, 0.5% BSA (w/v), and 0.1% Tween-20. May be stored at 4 °C for one week.
    5. Fluorescence In Situ Hybridization (FISH) Solutions.
      1. Prepare 20X Sodium chloride-Sodium Citrate (SSC): 3 M sodium chloride and 0.3 M sodium citrate.
      2. Prepare 2x SSC-Tween-20 (SSCT): 2x SSC plus 0.1% Tween-20. Make fresh, ~20 ml per oocyte prep.
      3. Prepare formamide solutions: 2x SSC, 0.1% Tween-20, plus formamide. Make fresh, 1 ml 20% formamide, 0.5 ml 40% formamide, and 2 ml 50% formamide per oocyte prep.
        CAUTION: Wear gloves while using formamide solutions in a fume hood. Dispose of waste according to institutional guidelines.
      4. Prepare hybridization solution: 2x SSC, 50% formamide, and 10% dextran sulfate (w/v). Store at 4 °C.
    6. FISH Probes.
      1. Order oligonucleotides (see Table 1 for sequences) with HPLC purification and desired 5' fluorescent modification (e.g., Cy3 or Cy5). Resuspend in Tris-EDTA (TE) at 50 ng/µl.
        ​NOTE: Protect oligos from light exposure at all times.

2. Collection of Late-stage Drosophila Oocytes

  1. As Drosophila oocytes with membranes intact will stick to plastic and glass, pre-coat the inside of one 5 ml tube and one Pasteur pipet per oocyte prep with PTB.
  2. Anesthetize all ~100 to 300 yeasted flies with carbon dioxide and add to a blender containing ~100 ml 1x Robb's Buffer. Pulse three times (~1 sec each). Keep oocytes in Robb's for <20 min to avoid activation.
    NOTE: Alternatively, oocytes may be hand-dissected from females. The advantage of this method is that it requires less females. However, care must be taken to limit exposure to carbon dioxide to only a few minutes to avoid artifacts associated with hypoxia7.
  3. Filter through large mesh (~1,500 µm) into 250 ml beaker to remove large body parts. If many intact abdomens remain on mesh, re-grind material using additional Robb's Buffer, and filter again. Let settle ~2 min, then aspirate off top layer, removing as many of the large body parts as possible.
  4. Filter through small mesh (~300 µm) into a 250 ml beaker. Rinse remaining oocytes out of first beaker using additional Robb's and coated Pasteur pipet. Let settle ~3 min; oocytes will settle out. Aspirate off all but ~10 ml.
  5. Pour as much of the 10 ml as will fit into coated 5 ml tube. Let settle, remove liquid, and repeat with remainder. Rinse remaining oocytes out of beaker using additional Robb's and coated Pasteur pipet. Let settle in 5 ml tube for ~3-5 min.

3. Drug Treatments (Optional)

  1. Coat a second 5 ml tube with PTB for each oocyte prep. Add appropriate solvent (control) or drug to 1 ml Robb's each for each oocyte prep (Table 2).
  2. Split oocytes into second coated 5 ml tube. Let settle, remove liquid, and add 1 ml Robb's plus solvent into one tube and 1 ml Robb's plus drug into second tube. Nutate for appropriate amount of time for drug treatment (Table 2). Let settle.

4. Fixation

  1. Aspirate off all liquid and immediately add 1 ml Fix.
  2. Option #1: Formaldehyde/heptane fixation (Fixation Buffer plus 5% formaldehyde).
    1. Fix for 2.5 min on a nutator. Add 1 ml heptane and vortex 1 min. Let settle ~1 min.
    2. Remove all liquid, and then add 1 ml 1x PBS. Vortex 30 sec. Let settle ~1 min.
    3. Remove all liquid, and then fill tube with 1x PBS.
      NOTE: Oocytes may be used immediately or kept on the nutator for several hours at room temperature.
  3. Option #2: Formaldehyde/cacodylate fixation (Fix Mix plus 8% formaldehyde and 100 mM cacodylate).
    1. Fix for 6 min on a nutator. Let settle 2 min. Remove liquid, and then fill tube with 1x PBS.
      ​NOTE: Oocytes may be used immediately or kept on the nutator for several hours at room temperature.

5. Removing Membranes ("Rolling")

  1. Using coated Pasteur pipet, add ~500 to 1,000 oocytes to the frosted (sand-blasted) part of a glass slide. Remove all body parts and extraneous material using forceps. Do not let oocytes dry out; add 1x PBS as necessary.
  2. Place a coverslip on top of the oocytes and gently "roll" oocytes until all membranes are removed (dragging the edge of the coverslip across the oocytes works best.) Periodically check progress under the microscope, adding more 1x PBS as necessary. Take care as too much pressure will destroy the oocytes.
    ​NOTE: For immunofluorescence only, continue with Step 6. For FISH (with or without immunofluorescence), continue with Step 7.

6. Antibody Staining of Drosophila Oocytes

  1. Extraction and Blocking
    1. Rinse rolled oocytes into a 15 ml conical tube containing ~15 ml PBS/1% Triton X-100. Nutate oocytes in this solution for no less than 1.5 hr and no more than 2 hr. This step allows antibody penetration.
    2. Let oocytes settle ~2 min. Remove liquid along with as many membranes as possible, then add PBS/0.05% Triton X-100.
      ​NOTE: Membranes will settle slower than rolled oocytes.
    3. Let oocytes settle ~2 min, then remove all but ~1 ml liquid. Transfer oocytes to graduated 1.5 ml tube and remove remaining liquid. Add 1 ml PTB for blocking and nutate for 1 hr.
  2. Antibody Staining
    1. Pre-absorption of secondary antibodies against embryos.
      ​NOTE: This step eliminates background staining from non-specific antibody interactions with Drosophila proteins.
      1. Collect and fix Drosophila embryos (~25 µl) per typical procedure8. Store in methanol at -20 °C.
      2. Remove methanol from embryos, add 800 µl methanol plus 200 µl 1x PBS, and nutate for 15 min. Remove 500 µl of supernatant and replace with 500 µl 1x PBS. Then nutate for 15 min. Repeat twice (for a total of ~1 hr of washes), and then finish in PTB.
        ​NOTE: Embryos may be used immediately or kept on the nutator for several hr at room temperature.
      3. Remove liquid, fill with PTB to 200 µl per oocyte prep, and add fluorescently-labeled secondary antibodies at appropriate dilutions (keeping in mind that the final volume will be 300 µl; see step 7.4.) Nutate at 4 °C overnight (preferable) or at room temperature for 3 to 4 hr.
        NOTE: The pre-absorbed antibodies will be used in Step 6.2.4.
        ​NOTE: Keep samples in the dark as much as possible once fluorescent antibodies have been added.
    2. Remove liquid from oocytes, fill with PTB to 300 µl, and add primary antibodies at appropriate dilutions. Nutate at 4 °C overnight (preferable) or at room temperature for 3 to 4 hr.
    3. Wash oocytes four times for 15 min each with 1 ml PTB.
    4. Remove liquid from oocytes, add 200 µl of supernatant from embryos (pre-absorbed secondary antibodies). Then fill with PTB to 300 µl. Nutate at room temperature for 3 to 4 hr (preferable) or at 4 °C overnight.
    5. Wash oocytes once for 15 min with 1 ml PTB, remove liquid. Then add 0.5 µl Hoechst 33342 and 500 µl PTB and nutate for 7 min.
    6. Wash oocytes twice for 15 min each with 1 ml PTB.
      ​NOTE: Oocytes may be mounted on a slide immediately or may be stored in PTB at 4 °C until ready for imaging.

7. FISH (Continue from Step 5 Above)

  1. Rinse rolled oocytes into a 15 ml conical tube containing ~15 ml 2x SSCT. Let oocytes settle ~2 min. Remove all but ~0.5 ml liquid along with as many membranes as possible.
    NOTE: Membranes will settle slower than rolled oocytes.
  2. Transfer oocytes to 0.5 ml tube and remove remaining liquid. Successively add and remove 500 µl 20%, 40%, and 50% formamide solutions, nutating for 10 min in each solution.
    NOTE: Oocytes will settle slower with higher percentages of formamide.
  3. Remove liquid, then add 500 µl 50% formamide solution, and nutate at 37 °C for 1 to 5 hr.
    NOTE: Longer incubations result in better probe penetration.
  4. Remove liquid, leaving behind no more than ~100 µl oocytes, and add 36 µl hybridization solution plus 2 µl of probe (50 ng/µl) and 2 µl of water or 2 µl of a 2nd probe (Table 1).
  5. Incubate at 91 °C for 3 min (FISH only) or 80 °C for 20 min (FISH plus immunofluorescence), followed by incubation in a 37 °C water bath overnight.
    NOTE: These steps may be performed in a thermocycler.
  6. Do not remove liquid. Add 500 µl 50% formamide solution and nutate at 37 °C for 1 hr.
  7. Let settle, remove liquid, add 500 µl 50% formamide solution, and nutate at 37 °C for 1 hr.
  8. Let settle, remove liquid, add 500 µl 20% formamide solution, and nutate at room temperature for 10 min.
  9. Perform three quick washes in 500 µl 2x SSCT (let settle, remove then add liquid, invert several times, repeat.) Let settle, remove liquid, then add 500 µl PTB and nutate for 4 hr.

8. Antibody Staining after FISH

  1. Remove liquid from oocytes, fill with PTB to 300 µl, and add 10 µl anti-α-tubulin antibody conjugated to FITC. Alternatively, other antibodies can be used, following above protocol. Nutate at room temperature overnight.
  2. Wash oocytes once for 15 min with 500 µl PTB, remove liquid, then add 0.5 µl Hoechst 33342 and 500 µl PTB and nutate for 7 min.
  3. Wash oocytes twice for 15 min each with 500 µl PTB.
    NOTE: Oocytes may be mounted on a slide immediately or may be stored in PTB at 4 °C until ready for imaging. Keep oocytes in the dark as much as possible once fluorescent antibodies have been added.
Repeat NameChromosomeOligo Sequence*
359XGGGATCGTTAGCACTGGTAATTAGCTGC
AACAC2AACACAACACAACACAACACAACACAACACAACACAACAC
dodeca3CCCGTACTGGTCCCGTACTCGGTCCCGTACTCGGT
1.6862+3AATAACATAGAATAACATAGAATAACATAG
AATAT4(+Y)AATATAATATAATATAATATAATATAATAT
*359 sequence from Eric Joyce, personal communication, other sequences from Sullivan et al.8

Table 1: FISH probes for Drosophila centromeric repeats.

DrugSolventStock concentrationFinal concentrationTime of treatmentEffect
colchicineethanol125 mM150 µM10 min or 30 mindestabilize non-kinetochore (10 min)9 or all (30 min) microtubules
paclitaxelDMSO10 mM10 µM10 minstabilize microtubules
Binucleine 2DMSO25 mM25 µM20 mininhibit Aurora B kinase10

Table 2: Drug treatment.

Wyniki

The methods we have described here will result in the collection of late-stage Drosophila oocytes representing three stages of meiosis (Figure 1). Oocytes in prophase are distinguished by the presence of the nuclear envelope, which is visible by the lack of tubulin signal in the region surrounding the karyosome (Figure 1A). Prometaphase is the period after nuclear envelope breakdown during which the spindle assembles. During prometaphase, the kar...

Dyskusje

Staging Drosophila Oocytes

Although an elongated karyosome is often seen in prometaphase oocytes, using karyosome shape to distinguish prometaphase from metaphase oocytes can be problematic. During prometaphase, the karyosome begins as a round shape, elongates, and then retracts to a round shape as the oocyte approaches the metaphase arrest. This means that many prometaphase oocytes do not have an elongated karyosome. In addition, if mutant or drug-treated oocytes are...

Ujawnienia

The authors have nothing to disclose.

Podziękowania

We thank Christian Lehner for providing the CENP-C antibody and Eric Joyce for recommendations on FISH. Work in the McKim lab was funded by a grant from NIH (GM101955).

Materiały

NameCompanyCatalog NumberComments
15 ml conical tubesVarious
16% formaldehydeTed Pella, Inc.18505HAZARDOUS; once opened, discard after one month
250 ml beakersVarious
5 ml tubesVarious
active dry yeastVariousmix with water to make a paste the consistency of peanut butter
anti-α-tubulin antibody conjugated to FITCSigmaF2168clone DM1A
Binucleine 2SigmaB1186HAZARDOUS
blenderVarious
bovine serum albuminSigmaA4161
calcium chlorideVarious
colchicineSigmaC-9754HAZARDOUS
coverslipsVWR48366-227No. 1 1/2
dextran sulfateVarious
DMSOVarious
EGTAVarious
ethanolVarious
forcepsTed Pella, Inc.5622Dumont tweezers high precision grade style 5
formamideSigma47670-250ML-F
glass slidesVWR48312-003
glucoseVarious
graduated 1.5 ml tubesVarious
HEPESVWREM-5330available from several venders
Hoechst 33342Various
magnesium chlorideVarious
methanolVarious
large mesh (~1,500 µm)VWRAA43657-NKvariety of formats and other suppliers, 12 or 14 mesh
small mesh (~300 µm)Spectrum labs146 424variety of formats, e.g., 146 422 or 146 486
nutatorVarious
Pasteur pipetsVarious
potassium acetateVarious
Cacodylic acidSigmaC0125HAZARDOUS; alternatively, sodium cacodylate may be substituted
potassium hydroxideVarious
sodium acetateVarious
sodium chlorideVarious
sodium citrateVarious
sodium hydroxideVarious
sucroseVarious
taxol (paclitaxel)SigmaT1912HAZARDOUS
Triton X-100FisherPI-28314
Tween 20FisherPI-28320
vortexVarious

Odniesienia

  1. Bridges, C. B. Non-disjunction as proof of the chromosome theory of heredity. Genetics. 1 (1), 1-52 (1916).
  2. Hassold, T., Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2 (4), 280-291 (2001).
  3. Theurkauf, W. E., Hawley, R. S. Meiotic spindle assembly in Drosophila females: behavior of nonexchange chromosomes and the effects of mutations in the nod kinesin-like protein. J Cell Biol. 116 (5), 1167-1180 (1992).
  4. Zou, J., Hallen, M. A., Yankel, C. D., Endow, S. A. A microtubule-destabilizing kinesin motor regulates spindle length and anchoring in oocytes. J Cell Biol. 180 (3), 459-466 (2008).
  5. Dernburg, A. F., Sedat, J. W., Hawley, R. S. Direct evidence of a role for heterochromatin in meiotic chromosome segregation. Cell. 86 (1), 135-146 (1996).
  6. Gilliland, W. D., Hughes, S. F., Vietti, D. R., Hawley, R. S. Congression of achiasmate chromosomes to the metaphase plate in Drosophila melanogaster oocytes. Dev Biol. 325 (1), 122-128 (2009).
  7. Gilliland, W. D., et al. Hypoxia transiently sequesters mps1 and polo to collagenase-sensitive filaments in Drosophila prometaphase oocytes. PLoS One. 4 (10), e7544 (2009).
  8. Sullivan, W., Ashburner, M., Hawley, R. S. . Drosophila Protocols. , (2000).
  9. Radford, S. J., Hoang, T. L., Głuszek, A. A., Ohkura, H., McKim, K. S. Lateral and End-On Kinetochore Attachments Are Coordinated to Achieve Bi-orientation in Drosophila Oocytes. PLoS Genet. 11 (10), e1005605 (2015).
  10. Smurnyy, Y., Toms, A. V., Hickson, G. R., Eck, M. J., Eggert, U. S. Binucleine 2, an isoform-specific inhibitor of Drosophila Aurora B kinase, provides insights into the mechanism of cytokinesis. ACS Chem Biol. 5 (11), 1015-1020 (2010).
  11. Mahowald, A. P., Goralski, T. J., Caulton, J. H. In vitro activation of Drosophila eggs. Dev Biol. 98 (2), 437-445 (1983).
  12. Page, A. W., Orr-Weaver, T. L. Activation of the meiotic divisions in Drosophila oocytes. Dev Biol. 183 (2), 195-207 (1997).
  13. Tavosanis, G., Llamazares, S., Goulielmos, G., Gonzalez, C. Essential role for gamma-tubulin in the acentriolar female meiotic spindle of Drosophila. EMBO J. 16 (8), 1809-1819 (1997).
  14. Endow, S. A., Komma, D. J. Spindle dynamics during meiosis in Drosophila oocytes. J Cell Biol. 137 (6), 1321-1336 (1997).
  15. Matthies, H. J., Clarkson, M., Saint, R. B., Namba, R., Hawley, R. S., Sullivan, W., Ashburner, M., Hawley, R. S. . Drosophila Protocols. , 67-85 (2000).
  16. Colombié, N., et al. Dual roles of Incenp crucial to the assembly of the acentrosomal metaphase spindle in female meiosis. Development. 135 (19), 3239-3246 (2008).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

MeiosisDrosophila OocytesSpindle AssemblyChromosome OrientationImmunofluorescenceROB s BufferOocyte IsolationTissue FixationHeptanePBS

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone